2
Participants
Start Date
May 21, 2021
Primary Completion Date
December 9, 2021
Study Completion Date
February 6, 2022
Disulfiram
Patients will be instructed to self-administer disulfiram and copper gluconate twice daily at the assigned dose level. Both medications will be administered in 28-day cycles.
Copper Gluconate
Patients will be instructed to self-administer disulfiram and copper gluconate twice daily at the assigned dose level. Both medications will be administered in 28-day cycles.
Huntsman Cancer Institute, Salt Lake City
Collaborators (1)
Cantex Pharmaceuticals
INDUSTRY
University of Utah
OTHER